RT Conference Proceedings
T1 IMpower132: PFS and Safety Results with 1L Atezolizumab plus Carboplatin/Cisplatin plus Pemetrexed in Stage IV Non-Squamous NSCLC
A1 Papadimitrakopoulou, V.
A1 Cobo, M.
A1 Bordoni, R.
A1 Dubray-Longeras, P.
A1 Szalai, Z.
A1 Ursol, G.
A1 Novello, S.
A1 Orlandi, F.
A1 Ball, S.
A1 Goldschmidt, J., Jr.
A1 Sanborn, R.
A1 Hoang, T.
A1 Mendus, D.
A1 Deng, Y.
A1 Kowanetz, M.
A1 Wen, X.
A1 Lin, W.
A1 Sandler, A.
A1 Nishion, M.
K1 atezolizumab
K1 1L NSCLC
K1 chemotherapy
PB Elsevier science inc
SN 1556-0864
YR 2018
FD 2018-10-01
LK https://hdl.handle.net/10668/27903
UL https://hdl.handle.net/10668/27903
LA en
DS RISalud
RD Apr 17, 2025